<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04312477</url>
  </required_header>
  <id_info>
    <org_study_id>81830018-1</org_study_id>
    <nct_id>NCT04312477</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Modified Gegen Qinlian Decoction for Diarrhea-predominant Irritable Boewl Syndrome</brief_title>
  <official_title>The Correlation Within Diarrhea-predominant Irritable Boewl Syndrome(IBS-D) and Intestinal Microbiota Via C1orf106/Cytohesin-1（CYTH-1） /Adenosine Diphosphate-ribosylation Factor 6（ARF6） Signal Pathway and the Intervention Mechanism of Classic Chinese Compound Formula With Clearing Heat and Promoting Dieresis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xiyuan Hospital of China Academy of Chinese Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xiyuan Hospital of China Academy of Chinese Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diarrhea-predominant irritable boewl syndrome(IBS-D) seriously affect the quality of life in&#xD;
      patients. Clinically, it is effective to apply therapeutic method of clearing heat and&#xD;
      promoting diuresis to the common syndrome of dampness-heat. Dysbiosis of intestinal&#xD;
      microbiota is closely related to the immune imbalance and intestinal mucosal barrier injury.&#xD;
      C1orf106/CYTH-1/ARF6 signal pathway, which derive from intestinal micro environment&#xD;
      changes,is the mainly cause of intestinal mucosal barrier injury, and this is may be the&#xD;
      common pathogenesis of dampness-heat syndrome in IBS-D . Based on the clinic, the project is&#xD;
      to study the effect and mechanism of Chinese compound formula of clearing heat and promoting&#xD;
      dieresis in modulating intestinal microbiota dysbiosis, repairing intestinal mucosal barrier&#xD;
      and reconstructing intestinal microenvironment. With the combination of metagenomics and&#xD;
      metabonomics, the study compare the differences of co-metabolites of intestinal microbiota&#xD;
      and host within the healthy people, IBS-D patients with dampness-heat syndrome, to explore&#xD;
      the relevance between intestinal flora and host co-metabolites. Furthermore, the experimental&#xD;
      study is to clarify the drug targets via C1orf106/ CYTH-1/ARF6 signal pathway.Through the&#xD;
      study of association between dampness-heat syndrome in IBS-D and intestinal microbiota, it is&#xD;
      of important academic significance to reveal the Chinese theory intension of &quot;homotherapy for&#xD;
      heteropathy &quot;.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2020</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>IBS symptom severity (IBS-SSS)scale</measure>
    <time_frame>Change from Baseline disease activity at 4weeks</time_frame>
    <description>The IBS-SSS scale is scored from five aspects: the degree of abdominal pain, the frequency of abdominal pain, the degree of bloating, the degree of defecation satisfaction, and the impact on life.Each score is 0-100 points, and the total score is IBS-SSS scores from the degree of abdominal pain, the frequency of abdominal pain, the degree of abdominal distention, the satisfaction of defecation and the impact on life. Each score is 0-100, and the total score is 0-500. The higher the score, the more serious the disease is.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Clinical Global Impression of severity Scale ( CGI-S)</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bristol Stool Form Scale</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PRO scale</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The short form 36 (SF-36) health survey questionnaire</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The scores of TCM(Traditional Chinese Medicine) syndrome</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Diarrhea-predominant Irritable Boewl Syndrome</condition>
  <arm_group>
    <arm_group_label>Experimental group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Modified Gegen Qinlian Decoction, Oral, 7.2g per bag, 2 times / day, 30 minutes before breakfast and dinner</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bifico(Bifidobacterium triple viable capsule), orally，2 capsules/time, 2 days/time.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Modified Gegen Qinlian Decoction</intervention_name>
    <description>Modified Gegen Qinlian Decoction contains Pueraria lobata 24g, Scutellaria baicalensis 9g, Coptis chinensis 9g, artillery ginger 9g, talc 9g, roasted licorice 6g, and granules are prepared according to 10:1 production process.</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Experimental group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. It meets the diagnostic criteria of diarrhea-predominant irritable boewl syndrome and&#xD;
             meets the diagnostic criteria for damp-heat syndrome.&#xD;
&#xD;
          2. Age between 18 and 70 years old.&#xD;
&#xD;
          3. Not taking antibiotics, steroids and other hormones, Chinese herbal preparations in&#xD;
             the past week (including) Probiotics such as oral and intravenous), microecological&#xD;
             preparations or yogurt.&#xD;
&#xD;
          4. The subject informed and voluntarily signed the informed consent form. ;&#xD;
&#xD;
          5. Have a certain reading ability&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with severe organ, liver, kidney and other major organ diseases,&#xD;
             hematopoietic system, nervous system or mental illness;&#xD;
&#xD;
          2. combined with other digestive systemic lesions (such as peptic ulcer), or systemic&#xD;
             diseases affecting digestive tract motility (eg hyperthyroidism, diabetes);&#xD;
&#xD;
          3. Those who are or need to continue to use drugs that may affect gastrointestinal&#xD;
             function (antidiarrheals, antidepressants, anxiolytics, intestinal flora regulators,&#xD;
             antibiotics, etc.);&#xD;
&#xD;
          4. Those with a history of allergic reactions to related drugs and a history of severe&#xD;
             food allergies.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jiaqi Zhang, MD</last_name>
    <phone>+8615210595175</phone>
    <email>zjq405@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Xiyuanhospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100091</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiaqi Zhang, MD</last_name>
      <phone>+8615210595175</phone>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>January 15, 2020</study_first_submitted>
  <study_first_submitted_qc>March 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 18, 2020</study_first_posted>
  <last_update_submitted>March 13, 2020</last_update_submitted>
  <last_update_submitted_qc>March 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Diarrhea</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

